Member Info for moonparty

Yeah, ockhams razor principle - incompetence or jobs worth are the most likely culprits.

Nice response from the board today - gives me some confidence that they are acting properly.

Think I was right about someone at RPTC throwing their toys out of the pram!

There is definitely some games being played - perhaps the IPO directors said to RPTC something like "69p won't get voted through, you need to pay more", and some jobsworth in RPTC refused to accept this, and thus they have yesterdays announcement (which was through RPTC rather than IPO).

I hope it is something less toddler-tantrum-esque, but sadly I have enough experience to know better :)

The more I think about it, the more ridiculous this offer is.

The next 7 institutional holders by percentage (after Railways Pension) hold approx 20% of the company, and there is no way they will accept 69p, so these alone will be enough to reject the offer, let alone all the other institutions and private shareholders.

I don't really understand what is going on here - perhaps they are attempting some kind of lowball offer, but will be happy to pay more - I think enough holders would sell at 90p+ to make it viable?

If nothing else, it will be interesting to see the events unfold.

Could the long wait for news be drawing to a close?

I have bought back the ones I sold at 71p, reasons:

- offer might go ahead, and that's an easy 10% from this mornings prices.

- there may be other offers forthcoming now this one has been made official.

- if the offer gets voted out (my preferred option), I would expect/hope for a management shake-up and reinstatement of share buy-backs or other tactics to reward shareholders.

However, the management are, at best, inept, at worst self-serving with no interest in their shareholders, and that is the major risk factor.

Good luck all!

Nobody is going to vote for this, it's way too low an offer.

Suppose it might attract offers from other parties?

Luckily I sold 90% in the low 70's, and have been watching daily to get back in. If this is the only offer forthcoming, I think it will get voted down - no holders, except for 'Railways Pension Trustee Company Limited' are gonna go for it.

But honestly, what are the management thinking? How exactly is this in shareholder's interests? How on earth did they negotiate to such a bad offer price?

The volume seems to have dried up this morning. Price will have to rise to tempt more sellers, but wouldn't be surprised at a tree shake either.

Honestly, why is SpaceX available to the public?

Desperation or do we think Elon is actually a nice guy?

Avoid like the plague IMO, at least at the IPO price.

Breakingeven, just to caveat your point 1:

"Scancell can't of received any offers for the company at this point otherwise shareholders would have to be notified"

True only if the offer is a "firm declaration" - I am sure there are all kinds of conversations that are not "firm"

You can still sell in quantity - up to 500K on auto, so there are obviously willing buyers.

Thanks to those that are panicking, I have just managed to top up 150K at 20.8p. Brings me to a nice round number.

Joaung1, short answer - no, Scancell doesn't use p16-ARC antibodies, as far as I am aware. No mention of them in any Scancell literature.

Also it's adjuvant (post tumour removal), Scope trial is not.

Great results, not relevant for Scannell's scope iscib1+ target market

Very relaxed about news

If financing, even short term, was an issue they would have done a placing by now.

There is clearly a plan, and the sp trajectory indicates it is a value crystallising one.

Perfectly happy to sit back and enjoy a gradual sp rise.

Like taxiing to the runway before take off 😄

Pullback today was bound to happen at some point.

Lots of new shareholders on anything from 10% - 100% profit in the space of days or weeks.

If I was in their position and didn't understand properly what Scancell have I would also be tempted to take some profits.

IMO - as in all bull markets, buy the dips!

Spoke too soon :(

Sellers were in control briefly, normal service has been resumed :)

Just watched, thanks for the link Ray.

Phil did say the therapy works in 80% of patients, and he was talking about the whole patient pool (i.e. scib + modi1).

To me that is a hint that modi1 is doing at least as well as scib. Could be a slip of the tongue, and he only meant for scib, but it didn't come across that way.

Stevenmerret - think you are mistaken, Vulpes have not been trading Scancell, they may have sold and then bought back one time, but they are definitely not trading their stock routinely.

Just for clarification, I'm talking about the share price 😎